These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 22244599)

  • 1. Development and validation of the Composite Asthma Severity Index--an outcome measure for use in children and adolescents.
    Wildfire JJ; Gergen PJ; Sorkness CA; Mitchell HE; Calatroni A; Kattan M; Szefler SJ; Teach SJ; Bloomberg GR; Wood RA; Liu AH; Pongracic JA; Chmiel JF; Conroy K; Rivera-Sanchez Y; Busse WW; Morgan WJ
    J Allergy Clin Immunol; 2012 Mar; 129(3):694-701. PubMed ID: 22244599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asthma morbidity among inner-city adolescents receiving guidelines-based therapy: role of predictors in the setting of high adherence.
    Gruchalla RS; Sampson HA; Matsui E; David G; Gergen PJ; Calatroni A; Brown M; Liu AH; Bloomberg GR; Chmiel JF; Kumar R; Lamm C; Smartt E; Sorkness CA; Steinbach SF; Stone KD; Szefler SJ; Busse WW
    J Allergy Clin Immunol; 2009 Aug; 124(2):213-21, 221.e1. PubMed ID: 19615730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telehealth delivery of adherence and medication management system improves outcomes in inner-city children with asthma.
    Lin NY; Ramsey RR; Miller JL; McDowell KM; Zhang N; Hommel K; Guilbert TW
    Pediatr Pulmonol; 2020 Apr; 55(4):858-865. PubMed ID: 31905264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asthma symptoms, morbidity, and antiinflammatory use in inner-city children.
    Warman KL; Silver EJ; Stein RE
    Pediatrics; 2001 Aug; 108(2):277-82. PubMed ID: 11483788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the composite asthma severity index in a pediatric subspecialty clinic.
    Mokhallati N; Schuler CL; Thomas S; Hossian MM; Guilbert TW
    Ann Allergy Asthma Immunol; 2021 Jun; 126(6):702-706. PubMed ID: 33549639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse Sensitization and Exposure Are Associated with Asthma Severity in Urban Children.
    Grant T; Aloe C; Perzanowski M; Phipatanakul W; Bollinger ME; Miller R; Matsui EC
    J Allergy Clin Immunol Pract; 2017; 5(4):1008-1014.e1. PubMed ID: 27923647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current asthma guidelines may not identify young children who have experienced significant morbidity.
    Galant SP; Morphew T; Amaro S; Liao O
    Pediatrics; 2006 Apr; 117(4):1038-45. PubMed ID: 16585297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathways through which asthma risk factors contribute to asthma severity in inner-city children.
    Liu AH; Babineau DC; Krouse RZ; Zoratti EM; Pongracic JA; O'Connor GT; Wood RA; Khurana Hershey GK; Kercsmar CM; Gruchalla RS; Kattan M; Teach SJ; Makhija M; Pillai D; Lamm CI; Gern JE; Sigelman SM; Gergen PJ; Togias A; Visness CM; Busse WW
    J Allergy Clin Immunol; 2016 Oct; 138(4):1042-1050. PubMed ID: 27720018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007.
    National Asthma Education and Prevention Program
    J Allergy Clin Immunol; 2007 Nov; 120(5 Suppl):S94-138. PubMed ID: 17983880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between duration of asthma and asthma severity among children in the Childhood Asthma Management Program (CAMP).
    Zeiger RS; Dawson C; Weiss S
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):376-87. PubMed ID: 10069869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-IgE therapy for asthma: an audit at atertiary care centre in Saudi Arabia.
    Weheba IM; Abdelsayed AM; Arnaout RK; Zeitouni MO; Mobaireek KF; AlHarthi TB; Mobeireek AF
    Ann Saudi Med; 2018; 38(6):439-444. PubMed ID: 30531179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlling the Risk Domain in Pediatric Asthma through Personalized Care.
    Anderson WC; Szefler SJ
    Semin Respir Crit Care Med; 2018 Feb; 39(1):36-44. PubMed ID: 29427984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asthma control and need for future asthma controller therapy among inner-city Hispanic asthmatic children engaged in a pediatric asthma disease management program (the Breathmobile program, Mobile Asthma Care for Kids Network).
    Scott L; Li M; Thobani S; Nichols B; Morphew T; Kwong KY
    J Asthma; 2016 Aug; 53(6):629-34. PubMed ID: 27221537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asthma severity, not asthma control, is worse in atopic compared with nonatopic adolescents with asthma.
    Arroyave WD; Rabito FA; Carlson JC; Sever ML; Lefante J
    Ann Allergy Asthma Immunol; 2016 Jan; 116(1):18-25. PubMed ID: 26560898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agreement among measures of asthma status: a prospective study of low-income children with moderate to severe asthma.
    Sharek PJ; Mayer ML; Loewy L; Robinson TN; Shames RS; Umetsu DT; Bergman DA
    Pediatrics; 2002 Oct; 110(4):797-804. PubMed ID: 12359798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can we predict fall asthma exacerbations? Validation of the seasonal asthma exacerbation index.
    Hoch HE; Calatroni A; West JB; Liu AH; Gergen PJ; Gruchalla RS; Khurana Hershey GK; Kercsmar CM; Kim H; Lamm CI; Makhija MM; Mitchell HE; Teach SJ; Wildfire JJ; Busse WW; Szefler SJ
    J Allergy Clin Immunol; 2017 Oct; 140(4):1130-1137.e5. PubMed ID: 28238748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma.
    Chauhan BF; Jeyaraman MM; Singh Mann A; Lys J; Abou-Setta AM; Zarychanski R; Ducharme FM
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010347. PubMed ID: 28301050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinguishing characteristics of difficult-to-control asthma in inner-city children and adolescents.
    Pongracic JA; Krouse RZ; Babineau DC; Zoratti EM; Cohen RT; Wood RA; Khurana Hershey GK; Kercsmar CM; Gruchalla RS; Kattan M; Teach SJ; Johnson CC; Bacharier LB; Gern JE; Sigelman SM; Gergen PJ; Togias A; Visness CM; Busse WW; Liu AH
    J Allergy Clin Immunol; 2016 Oct; 138(4):1030-1041. PubMed ID: 27720017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group.
    FitzGerald JM; Chapman KR; Della Cioppa G; Stubbing D; Fairbarn MS; Till MD; Brambilla R
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):427-35. PubMed ID: 10069876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study.
    Chipps BE; Zeiger RS; Borish L; Wenzel SE; Yegin A; Hayden ML; Miller DP; Bleecker ER; Simons FE; Szefler SJ; Weiss ST; Haselkorn T;
    J Allergy Clin Immunol; 2012 Aug; 130(2):332-42.e10. PubMed ID: 22694932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.